Clinical Trials Directory

Trials / Completed

CompletedNCT05751460

Translation and Validation of Pelvic Girdle Questionnaire in Urdu Language

Status
Completed
Phase
Study type
Observational
Enrollment
125 (actual)
Sponsor
Riphah International University · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Urdu version of pelvic girdle questionnaire was drafted, tested for its reliability and validity on patients with pelvic girdle pain. Urdu version was linguistically acceptable and accurate for pregnant and post partum females with pelvic girdle pain. The result seems comparable to all the other versions and especially with original Norwegian version. This instrument is understandable and easy to find disability during pregnancy and post partum duration. It showed a good content, construct and convergent validity also present high internal consistency and test retest reliability.

Detailed description

The Pelvic Girdle Questionnaire is the only specific instrument designed to evaluate pain and activity limitations in pregnant or postpartum women with pelvic girdle pain. This study aimed to translate the Pelvic girdle questionnaire in Urdu language for Pakistani female patients and to verify the validation of the psychometric items of the Pelvic girdle questionnaire in population of Pakistan. The purpose of this study was to translate the Pelvic Girdle Questionnaire into Urdu and find out cross-culture validity and reliability of Urdu Pelvic girdle questionnaire among pregnant and postpartum females. A cultural adaptation and translation study was performing according to international guidelines. Study was conducted at different hospital settings. Pre test was conducted among 16 females during pregnancy \& post-partum. Key words: Disability Evaluation, Female, Urdu, Pelvic Girdle Pain and physiopathology, Pregnancy, Surveys and Questionnaires, Translation.

Conditions

Interventions

TypeNameDescription
OTHERStraight leg raiseDiagnostic test, tool for \*g\*

Timeline

Start date
2021-01-02
Primary completion
2022-01-31
Completion
2022-01-31
First posted
2023-03-02
Last updated
2023-03-02

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05751460. Inclusion in this directory is not an endorsement.